Manufacturers Life Insurance Company, The Ovid Therapeutics Inc. Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.72 - $4.04 $3,073 - $4,565	1,130 Added 4.55%	25,980 $79,000
Q2 2023 Aug 11, 2023	BUY	$2.53 - $3.89 $62,870 - $96,666	24,850 New	24,850 $81,000
Q2 2021 Aug 12, 2021	SELL	$3.3 - $4.49 $103,395 - $140,680	-31,332 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$2.42 - $4.47 $75,823 - $140,054	31,332 New	31,332 $126,000
Q4 2020 Feb 12, 2021	SELL	$2.28 - $6.84 $60,296 - $180,890	-26,446 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.67 - $7.91 $70,610 - $209,187	26,446 New	26,446 $203,000
Q3 2018 Nov 14, 2018	SELL	$5.6 - $11.0 $5,661 - $11,121	-1,011 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$6.53 - $9.82 $5,308 - $7,983	-813 Reduced 44.57%	1,011 $7,000
Q4 2017 Feb 08, 2018	BUY	$6.12 - $12.31 $5,452 - $10,968	891 Added 95.5%	1,824 $18,000
Q3 2017 Nov 14, 2017	BUY	$5.32 - $9.77 $4,963 - $9,115	933	933 $8,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.